Effects of Lavender Essential Oil in Patients With Chronic Heart Failure
Chronic Heart Failure
About this trial
This is an interventional treatment trial for Chronic Heart Failure focused on measuring Chronic Heart Failure, lavender essential oil, sleep quality, Anxiety Disorders, Fatigue
Eligibility Criteria
Inclusion Criteria: Met the diagnostic criteria of heart failure:cardiac function grade ⅱ-ⅲ, disease duration ≥6 months. Blood pressure ≥90/60mmH, heart rate ≥60 times/min. No malignant arrhythmia, no need for oxygen or mechanical ventilation. Pittsburgh sleep quality (PSQI) score > 5, State-trait anxiety scale (STAI) score 21-59. No nasal diseases, normal sense of smell. Normal hearing and language expression, able to communicate, volunteer to participate in this study. Exclusion Criteria: Pregnant women. Suffering from physical pain diseases or combined with tumors and other serious diseases of the system A history of mental illness, the use of psychiatric or sedative hypnotic drugs within 1 month. Allergic constitution, allergic to lavender essential oil or coconut oil, suffering from allergic rhinitis, eczema, asthma and other respiratory diseases. Declined to participate in this study.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Aromatherapy inhalation with lavender essential oil
Aromatherapy inhalation with coconut essential oil
Patients in this group will receive aromatherapy inhalation with lavender essential oil for 28 days , and their sleep quality, anxiety and fatigue will be evaluated at baseline, the 7th day, and 28th day.
Patients in this group will receive aromatherapy inhalation with coconut essential oil for 28 days , and their sleep quality, anxiety and fatigue will be evaluated at baseline, the 7th day, and 28th day.